Combined pituitary hormone deficiency: Role of Pit-1 and Prop-1

Acta Paediatrica, International Journal of Paediatrics, Supplement

Volumn 88, Issue 433, 1999, Pages 33-41

  Pfaffle R W ^a   Blankenstein, O ^a   Wuller S ^a   Kentrup, H ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Combined pituitary hormone deficiency; Growth hormone; Hypogonadism; Hypothyroidism; Mutation; Pit 1; Prop 1

Indexed keywords

TRANSCRIPTION FACTOR PIT 1;

ANIMAL EXPERIMENT; CELL DIFFERENTIATION; CONFERENCE PAPER; FRAMESHIFT MUTATION; GENE DELETION; GENETIC LINKAGE; GROWTH HORMONE DEFICIENCY; GROWTH REGULATION; HYPOGONADISM; HYPOPHYSIS CELL; HYPOTHYROIDISM; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ARGININE; DNA-BINDING PROTEINS; HOMEODOMAIN PROTEINS; HUMANS; MICE; MUTATION; PHENOTYPE; PITUITARY HORMONES; TRANSCRIPTION FACTOR PIT-1; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRYPTOPHAN;

EID: 0342905437     PISSN: 08035326     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (71)

1. Lacey KA, Parkin JM. Causes of short stature. A community study of children in Newcastle upon Tyne. Lancet 1974; 1: 42-5
2. Vimpani GV, Vimpani AF, Lidgard GP, Cameron EH, Farquhar JW. Prevalence of severe growth hormone deficiency. Br Med J 1977; 2: 427-30
3. Chen EY, Liao YC, Smith DH, Barrera-Saldana HA, Gelinas RE, Seeburg PH. The human growth hormone locus: nucleotide sequence, biology, and evolution. Genomics 1989; 4: 479-97
4. Phillips JA, Beamer WG, Bartke A. Analysis of growth hormone genes in mice with genetic defects of growth hormone expression, J Endocrinol 1982; 92: 405-7
5. Phillips JA. Inherited defects in growth hormone synthesis and action. In: Scriver CR, Beaudet AL, Sly WS, Vaele D, editors. The metabolic basis of inherited disease. New York: McGraw-Hill, 1989: 1965-83
6. Procter AM, Phillips JA, Cooper DN. The molecular genetics of growth hormone deficiency. Hum Genet 1998; 103: 255-72
7. Akinci A, Kanaka C, Eble A, Akar N, Vidinlisan S, Mullis PE. Isolated growth hormone (GH) deficiency type IA associated with a 45-kilobase gene deletion within the human GH gene cluster. J Clin Endocrinol Metab 1992; 75: 437-41
8. Cacciari E, Pirazzoli P, Gualandi S, Baroncini C, Baldazzi L, Trevisani B, et al. Molecular study of human growth hormone gene cluster in three families with isolated growth hormone deficiency and similar phenotype. Eur J Pediatr 1994; 153: 635-41
9. Wagner JK, Eble A, Hindmarsh PC, Mullis PE. Prevalence of human GH-1 gene alterations in patients with isolated growth hormone deficiency. Pediatr Res 1998; 43: 105-10
10. Illig R. Growth hormone antibodies in patients treated with different preparations of human growth hormone (HGH). J Clin Endocrinol Metab 1970; 31: 679-88
11. Laron Z, Kelijman M, Pertzelan A, Keret R, Shoffner JM, Parks JS. Human growth hormone gene deletion without antibody formation or growth arrest during treatment - a new disease entity? Isr J Med Sci 1985; 21: 999-1006
12. Braga S, Phillips JA, Joss E, Schwarz H, Zuppinger K. Familial growth hormone deficiency resulting from a 7.6 kb deletion within the growth hormone gene cluster. Am J Med Genet 1986; 25: 443-52
13. Hauffa BP, Illig R, Torresani T, Stolecke H, Phillips JA. Discordant immune and growth response to pituitary and biosynthetic growth hormone in siblings with isolated growth hormone deficiency type IA. Acta Endocrinol (Copenh) 1989; 121: 609-14
14. Cogan JD, Phillips JA. Growth disorders caused by genetic defects in the growth hormone pathway. Adv Pediatr 1998; 45: 337-61
15. Igarashi Y, Ogawa M, Kamijo T, Iwatani N, Nishi Y, Kohno H, et al. A new mutation causing inherited growth hormone deficiency: a compound heterozygote of a 6.7 kb deletion and a two base deletion in the third exon of the GH-1 gene. Hum Mol Genet 1993; 2: 1073-4
16. Binder G, Ranke MB. Screening for growth hormone (GH) gene splice-site mutations in sporadic cases with severe isolated GH deficiency using ectopic transcript analysis. J Clin Endocrinol Metab 1995; 80: 1247-52
17. Cogan JD, Ramel B, Lehto M, Phillips JA, Prince M, Blizzard RM, et al. A recurring dominant negative mutation causes autosomal dominant growth hormone deficiency - a clinical research center study. J Clin Endocrinol Metab 1995; 80: 3591-5
18. Binder G, Brown M, Parks JS. Mechanisms responsible for dominant expression of human growth hormone gene mutations. J Clin Endocrinol Metab 1996; 81: 4047-50
19. Cogan JD, Prince MA, Lekhakula S, Bundey S, Futrakul A, McCarthy EM, et al. A novel mechanism of aberrant pre-mRNA splicing in humans. Hum Mol Genet 1997; 6: 909-12
20. Treier M, Rosenfeld MG. The hypothalamic-pituitary axis: co-development of two organs. Curr Opin Cell Biol 1996; 8: 833-43
21. Rosenfeld MG, Bach I, Erkman L, Li P, Lin C, Lin S, et al. Transcriptional control of cell phenotypes in the neuroendocrine system. Recent Prog Horm Res 1996; 51: 217-38
22. Simmons DM, Voss JW, Ingraham HA, Holloway JM, Broide RS, Rosenfeld MG, et al. Pituitary cell phenotypes involve cell-specific Pit-1 mRNA translation and synergistic interactions with other classes of transcription factors. Genes Dev 1990; 4: 695-711
23. Japon MA, Rubinstein M, Low MJ. In situ hybridization analysis of anterior pituitary hormone gene expression during fetal mouse development. J Histochem Cytochem 1994; 42: 1117-25
24. Sornson MW, Wu W, Dasen JS, Flynn SE, Norman DJ, SM OC, et al. Pituitary lineage determination by the Prophet of Pit-1 homeodomain factor defective in Ames dwarfism. Nature 1996; 384: 327-33
25. Gehring WJ. Homeo boxes in the study of development. Science 1987; 236: 1245-52
26. Gehring WJ, Hiromi Y. Homeotic genes and the homeobox. Anuu Rev Genet 1986; 20: 147-73
27. Lemaigre FP, Courtois SJ, Durviaux SM, Egan CJ, LaFontaine DA, Rousseau GG. Analysis of cis- and trans-acting elements in the hormone-sensitive human somatotropin gene promoter. J Steroid Biochem 1989; 34: 79-83
28. Lemaigre FP, Courtois SJ, Lafontaine DA, Rousseau GG. Evidence that the upstream stimulatory factor and the Sp1 transcription factor bind in vitro to the promoter of the human-growth-hormone gene. Eur J Biochem 1989; 181: 555-61
29. Lemaigre FP, Peers B, Lafontaine DA, Mathy-Hartert M, Rousseau GG, Belayew A, et al. Pituitary-specific factor binding to the human prolactin, growth hormone, and placental lactogen genes. DNA 1989; 8: 149-59
30. Nelson C, Albert VR, Elsholtz HP, Lu LI, Rosenfeld MG. Activation of cell-specific expression of rat growth hormone and prolactin genes by a common transcription factor. Science 1988; 239: 1400-5
31. Ingraham HA, Chen RP, Mangalam HJ, Elsholtz HP, Flynn SE, Lin CR, et al. A tissue-specific transcription factor containing a homeodomain specifies a pituitary phenotype. Cell 1988; 55: 519-29
32. Argenton F, Vianello S, Bernardini S, Jacquemin P, Martial J, Belayew A, et al. The transcriptional regulation of the growth hormone gene is conserved in vertebrate evolution. Biochem Biophys Res Commun 1993; 192: 1360-6
33. Ingraham HA, Albert VR, Chen RP, Crenshaw EB, Elsholtz HP, He X, et al. A family of POU-domain and Pit-1 tissue-specific transcription factors in pituitary and neuroendocrine development. Annu Rev Physiol 1990; 52: 773-91
34. Steinfelder HJ, Hauser P, Nakayama Y, Radovick S, McClaskey JH, Taylor T, et al. Thyrotropin-releasing hormone regulation of human TSHB expression: role of a pituitary-specific transcription factor (Pit-1/GHF-1) and potential interaction with a thyroid hormone-inhibitory element. Proc Natl Acad Sci USA 1991; 88: 3130-4
35. Mangalam HJ, Albert VR, Ingraham HA, Kapiloff M, Wilson L, Nelson C, et al. A pituitary POU domain protein, Pit-1, activates both growth hormone and prolactin promoters transcriptionally. Genes Dev 1989; 3: 946-58
36. Petersenn S, Rasch AC, Heyens M, Schulte HM. Structure and regulation of the human growth hormone-releasing hormone receptor gene. Mol Endocrinol 1998; 12: 233-47
37. Duquesnoy RJ. The pituitary dwarf mouse: a model for study of endocrine immunodeficiency disease. Birth Defects Orig Artic Ser 1975; 11: 536-43
38. Li S, Crenshaw EB, Rawson EJ, Simmons DM, Swanson LW, Rosenfeld MG. Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene pit-1. Nature 1990; 347: 528-33
39. Lorens JB, Aasland R, Brunstad H, Bergh H, Male R. Two variants of the pituitary specific transcription factor Pit-1 in Atlantic salmon. J Mol Endocrinol 1996; 17: 225-36
40. Herr W, Sturm RA, Clerc RG, Corcoran LM, Baltimore D, Sharp PA, et al. The POU domain: a large conserved region in the mammalian pit-1, oct-1, oct-2, and Caenorhabditis elegans unc-86 gene products. Genes Dev 1988; 2: 1513-6
41. Pfäffle RW, Kim C, Otten B, Wit JM, Eiholzer U, Heimann G, et al. Pit-1: clinical aspects. Horm Res 1996; 45: 25-8
42. Tatsumi K, Miyai K, Notomi T, Kaibe K, Amino N, Mizuno Y, et al. Cretinism with combined hormone deficiency caused by a mutation in the PIT1 gene. Nat Genet 1992; 1: 56-8
43. Pfäffle RW, DiMattia GE, Parks JS, Brown MR, Wit JM, Jansen M, et al. Mutation of the POU-specific domain of Pit-1 and hypopituitarism without pituitary hypoplasia. Science 1992; 257: 1118-21
44. Radovick S, Nations M, Du Y, Berg LA, Weintraub BD, Wondisford FE. A mutation in the POU-homeodomain of Pit-1 responsible for combined pituitary hormone deficiency. Science 1992; 257: 1115-8
45. Ohta K, Nobukuni Y, Mitsubuchi H, Fujimoto S, Matsuo N, Inagaki H, et al. Mutations in the Pit-1 gene in children with combined pituitary hormone deficiency. Biochem Biophys Res Commun 1992; 189: 851-5
46. Irie Y, Tatsumi K, Ogawa M, Kamijo T, Preeyasombat C, Suprasongsin C, et al. A novel E250X mutation of the PIT1 gene in a patient with combined pituitary hormone deficiency. Endocr J 1995; 42: 351-4
47. Pellegrini-Bouiller I, Belicar P, Barlier A, Gunz G, Charvet JP, Jaquet P, et al. A new mutation of the gene encoding the transcription factor Pit-1 is responsible for combined pituitary hormone deficiency. J Clin Endocrinol Metab 1996; 81: 2790-6
48. Okamoto N, Wada Y, Ida S, Koga R, Ozono K, Chiyo H, et al. Monoallelic expression of normal mRNA in the PIT1 mutation heterozygotes with normal phenotype and biallelic expression in the abnormal phenotype. Hum Mol Genet 1994; 3: 1565-8
49. Pfäffle RW, Otten B, Eiholzer U, Kim C, Blankenstein O. A genetic cause of familial and sporadic cases with combined pituitary hormone deficiencies for GH, Pr1 and TSH. Horm Res 1995; 44: 9 (abstract)
50. Cohen LE, Wondisford FE, Salvatoni A, Maghnie M, Brucker Davis F, Weintraub BD, et al. A "hot spot" in the Pit-1 gene responsible for combined pituitary hormone deficiency: clinical and molecular correlates. J Clin Endocrinol Metab 1995; 80: 679-84
51. de Zegher F, Pernasetti F, Vanhole C, Devlieger H, Van den Berghe G, Martial JA. The prenatal role of thyroid hormone evidenced by fetomaternal Pit-1 deficiency. J Clin Endocrinol Metab 1995; 80: 3127-30
52. Aarskog D, Eiken HG, Bjerknes R, Myking OL. Pituitary dwarfism in the R271W Pit-1 gene mutation. Eur J Pediatr 1997; 156: 829-34
53. Ward L, Chavez M, Huot C, Lecocq P, Collu R, Decarie JC, et al. Severe congenital hypopituitarism with low prolactin levels and age-dependent anterior pituitary hypoplasia: a clue to a PIT-1 mutation. J Pediatr 1998; 132: 1036-8
54. Buckwalter MS, Katz RW, Camper SA. Localization of the panhypopituitary dwarf mutation (df) on mouse chromosome 11 in an intersubspecific backcross. Genomics 1991; 10: 515-26
55. Camper SA, Saunders TL, Katz RW, Reeves RH. The Pit-1 transcription factor gene is a candidate for the murine Snell dwarf mutation. Genomics 1990; 8: 586-90
56. Andersen B, Pearse RV, Jenne K, Sornson M, Lin SC, Bartke A, et al. The Ames dwarf gene is required for Pit-1 gene activation. Dev Biol 1995; 172: 495-503
57. Duquesnoy P, Roy A, Dastot F, Ghali I, Teinturier C, Netchine I, et al. Human Prop-1: cloning, mapping, genomic structure. Mutations in familial combined pituitary hormone deficiency. FEBS Lett 1998; 437: 216-20
58. Wu W, Cogan JD, Pfäffle RW, Dasen JS, Frisch H, O'Connell SM, et al. Mutations in PROP1 cause familial combined pituitary hormone deficiency. Nat Genet 1998; 18: 147-9
59. Fluck C, Deladoey J, Rutishauser K, Eble A, Marti U, Wu W, et al. Phenotypic variability in familial combined pituitary hormone deficiency caused by a PROP1 gene mutation resulting in the substitution of Arg→Cys at codon 120 (R120C). J Clin Endocrinol Metab 1998; 83: 3727-34
60. Fofanova O, Takamura N, Kinoshita E, Parks JS, Brown MR, Peterkova VA, et al. Compound heterozygous deletion of the PROP-1 gene in children with combined pituitary hormone deficiency. J Clin Endocrinol Metab 1998; 83: 2601-4
61. Cogan JD, Wu W, Phillips JA, Arnhold IJ, Agapito A, Fofanova OV, et al. The PROP1 2-base pair deletion is a common cause of combined pituitary hormone deficiency. J Clin Endocrinol Metab 1998; 83: 3346-9
62. Rosenbloom AL, Almonte AS, Brown MR, Fisher DA, Baumbach L, Parks JS. Clinical and biochemical phenotype of familial anterior hypopituitarism from mutation of the PROP1 gene. J Clin Endocrinol Metab 1999; 84: 50-7
63. Mendonca BB, Osorio MG, Latronico AC, Estefan V, Lo LS, Arnhold IJ. Longitudinal hormonal and pituitary imaging changes in two females with combined pituitary hormone deficiency due to deletion of A301,G302 in the PROP1 gene. J Clin Endocrinol Metab 1999; 84: 942-5
64. Lanctot C, Gauthier Y, Drouin J, Pituitary homeobox 1 (Ptx1) is differentially expressed during pituitary development. Endocrinology 1999; 140: 1416-22
65. Dattani MT, Martinez-Barbera JP, Thomas PQ, Brickman JM, Gupta R, Mårtensson IL, et al. Mutations in the homeobox gene HESX1/Hesx1 associated with septo-optic dysplasia in human and mouse. Nat Genet 1998; 19: 125-33
66. Ward I, Chavez M, Huot C, Lecocq P, Martial JA, Van Vliet G. Severe combined pituitary hormone deficiency due to a Pit-1 mutation in a French-Canadian boy. Horm Res 1997; 48(Suppl 2): 201 (abstract)
67. Pfäffle RW, Parks JS, Brown MR, Ingraham HA, DiMattia G, Wit JM. A mutation of Pit-1 in two families with multiple pituitary hormone deficiency. Eur J Pediatr 1992; 151: 229-40
68. Pfäffle RW, Martinez R, Kim C, Frisch H, Lebl J, Otten B, et al. GH and TSH deficiency. Exp Clin Endocrinol Diabetes 1997; 105(Suppl 4): 1-5
69. Brown MR, Parks JS, Adess ME, Rich BH, Rosenthal IM, Voss TC, et al. Central hypothyroidism reveals compound heterozygous mutations in the Pit-1 gene. Horm Res 1998; 49: 98-102
70. Bakker B, Jansen M, Hendriks-Stegeman B. A new mutation in the Pit-1 gene, discovered by the neonatal congenital hypothyroidism (CH) screening program. Horm Res 1997; 48(Suppl 2): 201 (abstract)
71. Pernasetti F, Milner RD, al Ashwal AA, de Zegher F, Chavez VM, Muller M, et al. Pro239Ser: a novel recessive mutation of the Pit-1 gene in seven Middle Eastern children with growth hormone, prolactin, and thyrotropin deficiency. J Clin Endocrinol Metab 1998; 83: 2079-83